SERPING1, a biomarker associated with colorectal liver metastasis, promotes colorectal cancer cell proliferation, migration, and invasion

Authors:

Abstract
BackgroundColorectal liver metastasis (CRLM) is a major cause of mortality in patients with colorectal cancer (CRC). However, the underlying molecular mechanisms remain unclear. Therefore, identifying the key genes associated with CRLM and elucidating their functional roles are of critical importance.MethodsWeighted gene co-expression network analysis (WGCNA), differential expression analysis, and Kaplan–Meier survival analysis were performed to identify the CRLM-associated hub genes. SERPING1 expression was validated in human tissue samples. In vitro assays were performed to assess the effects of SERPING1 on CRC cell proliferation, migration, and invasion. Epithelial–mesenchymal transition (EMT)-related pathways were also analyzed. Single-cell RNA sequencing data were used to explore the involvement of SERPING1 in the tumor microenvironment.ResultsSERPING1 was identified as a hub gene associated with CRLM, and was significantly upregulated in CRLM tissues. Functional assays demonstrated that SERPING1 promotes CRC cell proliferation, migration, and invasion and is associated with the activation of EMT-related pathways. Single-cell RNA sequencing analysis revealed that SERPING1 was predominantly enriched in cancer-associated fibroblasts (CAFs) and was correlated with immune infiltration patterns related to CAFs.ConclusionsThese findings suggest that SERPING1 may play a pro-metastatic role in CRLM and represents a promising biomarker and potential therapeutic target for colorectal liver metastasis.